Insiders have been trading these 5 stocks: ((OKLO)), ((APP)), ((TEVA)), ((FSLY)) and ((INTU)). Here is a breakdown of their recent trades and their value.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CFO Richard Craig Bealmear’s recent move at Oklo Inc is turning heads after he sold 75,000 shares of the company’s stock in a single transaction. The sale, valued at $5,872,622, signals a significant cash-out by a key insider with deep insight into Oklo’s financial health and future prospects. While insider selling does not automatically mean trouble ahead, the size of this transaction inevitably invites investor scrutiny and speculation about whether Bealmear is simply taking profits or reacting to internal expectations about the company’s trajectory. For current and prospective shareholders, monitoring subsequent insider activity and upcoming earnings will be crucial in interpreting what this $5.87 million sale might really suggest about Oklo’s outlook.
At AppLovin, CALO & Corporate Secretary Victoria Valenzuela has also stepped into the spotlight with a notable insider transaction of her own, selling 7,609 shares of AppLovin stock. The sale totals a striking $5,000,102, underscoring how valuable AppLovin’s shares have become at current market levels. Such a large dollar-value trade from a senior legal and administrative officer can raise questions about whether she sees limited upside in the near term or is simply diversifying personal holdings after a strong run in the stock. Investors tracking AppLovin’s growth in mobile app monetization and advertising technology may want to weigh this multimillion-dollar insider sale against the company’s fundamentals and future guidance.
Teva Pharmaceutical has seen a flurry of insider activity, with two high-level executives locking in sizable gains. Director Roberto Mignone sold 77,400 shares of Teva Pharmaceutical stock in a deal worth $2,340,576, suggesting a meaningful reduction in his equity exposure. Adding to the signal, CAO Amir Weiss executed his own sale of 12,300 shares, bringing in $371,460. Taken together, these transactions total 89,700 shares sold for combined proceeds of $2,712,036. Multiple insiders selling in close proximity often amplifies investor curiosity, prompting closer examination of Teva’s pipeline, debt strategy, and legal overhangs as shareholders assess whether this represents routine profit-taking or a more cautious stance on the company’s near-term performance.
Fastly has joined the list of companies with notable insider selling, as President, Go to Market, Scott R. Lovett offloaded 34,517 shares of Fastly stock. The transaction, worth $350,347, highlights a substantial move by an executive who sits at the center of the company’s growth and customer acquisition strategy. Given that Fastly operates in the competitive edge computing and content delivery network space, any major insider trade can spark investor debate about the sustainability of its revenue growth and margin improvement. Although $350,347 is modest compared to some mega-cap insider sales, Lovett’s sale of 34,517 shares still represents a meaningful personal portfolio adjustment that market watchers will add to their broader assessment of sentiment within Fastly’s leadership team.
At Intuit, the financial narrative includes a significant transaction from EVP & CFO Sandeep Aujla, who sold 1,098 shares of Intuit stock. Despite the relatively small share count, the sale is striking in value, totaling $741,150, which underscores the high per-share price of Intuit’s stock amid strong demand for its financial software and tax preparation platforms. As the executive responsible for overseeing Intuit’s financial strategy and capital allocation, Aujla’s decision to monetize part of his holdings will inevitably draw attention from investors tracking insider confidence. While a single sale of 1,098 shares is unlikely to alter the long-term thesis on Intuit, the $741,150 transaction will be another data point for shareholders evaluating how leadership is positioning itself as the company navigates competition, AI-driven innovation, and evolving regulatory landscapes in the financial technology sector.

